<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Lilleri, Daniele</dc:creator>
  <dc:creator>Kabanova, Anna</dc:creator>
  <dc:creator>Revello, Maria Grazia</dc:creator>
  <dc:creator>Percivalle, Elena</dc:creator>
  <dc:creator>Sarasini, Antonella</dc:creator>
  <dc:creator>Genini, Emilia</dc:creator>
  <dc:creator>Sallusto, Federica</dc:creator>
  <dc:creator>Lanzavecchia, Antonio</dc:creator>
  <dc:creator>Corti, Davide</dc:creator>
  <dc:creator>Gerna, Giuseppe</dc:creator>
  <dc:date>2013-03-29</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Primary human cytomegalovirus (HCMV) infections during pregnancy are associated with a high risk of  virus transmission to the fetus. To identify correlates of intrauterine HCMV transmission, serial serum  samples from HCMV transmitter and non-transmitter pregnant women with primary HCMV infection were  analyzed for the presence of neutralizing antibodies against different glycoproteins and glycoprotein  complexes, which are known to mediate entry into distinct types of host cells. Neutralizing activity was  detected in the sera early after primary infection; absorption with a soluble pentameric complex formed  by gH/gL/pUL128-131, but not with gH/gL dimer or with gB, abolished the capacity of sera to neutralize  infection of epithelial cells. Importantly, an early, high antibody response to pentamer antigenic sites was  associated with a significantly reduced risk of HCMV transmission to the fetus. This association is  consistent with the high in vitro inhibition of HCMV infection of epithelial/endothelial cells as well as cell- to-cell spreading and virus transfer to leukocytes by anti-pentamer antibodies. Taken together, these  findings indicate that the HCMV pentamer complex is a major target of the antibody-mediated maternal  immunity.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/318884</dc:identifier>
  <dc:identifier>https://n2t.net/ark:/12658/srd1318884</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318884/files/Lilleri_PO_2013.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0059863</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318884</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Plos one. - 2013, vol. 8, no. 3, p. e59863</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
